Description
Enterolax-Stoma (sodium picosulfate) Tablets 7.5 mg. №10
Composition
Active ingredient: Sodium picosulfate.
Other ingredients: lactose monohydrate, maize starch, povidone, magnesium stearate.
Mechanism of Action
Sodium picosulfate, the active ingredient in Enterolax-Stoma tablets, is a stimulant laxative that acts by increasing intestinal motility, thereby facilitating bowel movements. This mechanism helps alleviate constipation by softening the stool and promoting its passage through the intestines.
Pharmacological Properties
Enterolax-Stoma tablets containing sodium picosulfate exert their laxative effects by stimulating the movement of the intestines, enhancing peristalsis, and facilitating the evacuation of stool. This results in the softening of fecal matter and increased bowel transit time, providing relief from constipation.
Indications for Use
Enterolax-Stoma tablets are indicated for the management of constipation, offering effective relief by promoting regular bowel movements and improving stool consistency.
Contraindications
Avoid using Enterolax-Stoma tablets if you have a known allergy to any of the ingredients present in the formulation. Additionally, these tablets are not recommended for use during pregnancy and lactation due to potential risks to the fetus or infant.
Side Effects
Common side effects associated with Enterolax-Stoma tablets may include abdominal discomfort, cramping, and diarrhea. If these symptoms persist or worsen, discontinue use and seek medical advice.
Usage Instructions
Recommended Dosage: Adults and children over 10 years should take 1-2 tablets of Enterolax-Stoma at bedtime.
It is essential not to exceed the prescribed dose to avoid adverse effects or complications.
Benefits Compared to Analogues
Enterolax-Stoma tablets offer a distinct advantage over traditional laxatives by providing targeted relief from constipation through the potent action of sodium picosulfate. This results in effective and prompt alleviation of symptoms with minimal side effects.
Suitable Patient Groups
Enterolax-Stoma tablets are suitable for use in various patient populations, including children over 10 years and the elderly, providing a safe and reliable option for managing constipation across different age groups.
Storage and Shelf Life
Store Enterolax-Stoma tablets in a cool, dry place away from direct sunlight. Ensure proper sealing of the packaging to maintain product integrity. Check the expiration date on the packaging and do not use the tablets beyond the specified shelf life.
Packaging Description
Enterolax-Stoma tablets are available in a package containing 10 tablets. The packaging is designed to ensure the stability and protection of the tablets, safeguarding their efficacy until consumption.
Clinical Evidence and Proven Effectiveness
Studies have demonstrated the efficacy of sodium picosulfate in treating constipation by enhancing bowel movements and improving stool consistency. Research published in the Journal of Gastroenterology and Hepatology highlighted the positive outcomes of sodium picosulfate therapy in patients with chronic constipation.
In a randomized controlled trial featured in the American Journal of Gastroenterology, sodium picosulfate exhibited superior efficacy compared to a placebo in relieving constipation and enhancing stool quality. These findings support the use of sodium picosulfate as a safe and effective treatment for constipation.
